Cite
Löschmann N, Michaelis M, Rothweiler F, et al. Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs. Transl Oncol. 2013;6(6):685-96doi: 10.1593/tlo.13544.
Löschmann, N., Michaelis, M., Rothweiler, F., Zehner, R., Cinatl, J., Voges, Y., Sharifi, M., Riecken, K., Meyer, J., von Deimling, A., Fichtner, I., Ghafourian, T., Westermann, F., & Cinatl, J. (2013). Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs. Translational oncology, 6(6), 685-96. https://doi.org/10.1593/tlo.13544
Löschmann, Nadine, et al. "Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs." Translational oncology vol. 6,6 (2013): 685-96. doi: https://doi.org/10.1593/tlo.13544
Löschmann N, Michaelis M, Rothweiler F, Zehner R, Cinatl J, Voges Y, Sharifi M, Riecken K, Meyer J, von Deimling A, Fichtner I, Ghafourian T, Westermann F, Cinatl J. Testing of SNS-032 in a Panel of Human Neuroblastoma Cell Lines with Acquired Resistance to a Broad Range of Drugs. Transl Oncol. 2013 Dec 01;6(6):685-96. doi: 10.1593/tlo.13544. eCollection 2013 Dec 01. PMID: 24466371; PMCID: PMC3890703.
Copy
Download .nbib